Carbocyclic analogues of lexitropsin - DNA affinity and endonuclease inhibition

Acta Poloniae Pharmaceutica - Drug Research

Volumn 64, Issue 2, 2007, Pages 115-119

  Pućkowska, Anna ^a   Drozdowska, Danuta ^a   Midura Nowaczek, Krystyna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Bis netropsin; DNA binding; Inhibition of endonuclease; Netropsin

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; CONGOCIDINE DERIVATIVE; DISTAMYCIN A; ENDONUCLEASE; LEXITROPSIN; PENTAMIDINE DERIVATIVE; BISBENZIMIDE; CARBOXYLIC ACID; CONGOCIDINE; DNA; DRUG DERIVATIVE; PENTAMIDINE;

ARTICLE; AT RICH SEQUENCE; BASE PAIRING; BINDING AFFINITY; CATALYSIS; DNA BINDING; DRUG STRUCTURE; ENZYME INHIBITION; BINDING COMPETITION; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; METABOLISM; STRUCTURE ACTIVITY RELATION;

ACIDS, CARBOCYCLIC; BINDING SITES; BINDING, COMPETITIVE; BISBENZIMIDE; DISTAMYCINS; DNA; ENDONUCLEASES; MOLECULAR STRUCTURE; NETROPSIN; PENTAMIDINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 35148888235     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Palumbo M.: Advances in DNA Sequence-Specific Agents. JAI Press Inc, London 1998.
2. Goodsell D. S.: Curr. Med. Chem. 8, 509 (2001).
3. Dervan P. B.: Bioorg. Med. Chem. 9, 2215 (2001).
4. Rao K. E., Sasisekharan V.: Indian J. Chem. 29B, 508 (1990).
5. Yan Y., Liu M., Gong B.: Bioorg. Med. Chem. Lett., 7, 1469 (1997).
6. Gong B., Yan Y.: Biochem. Biophys. Res. Commun. 240, 557 (1997).
7. Warner P. M., Qi J., Meng B., Li G., Xie L., El-Shafey A., Jones G. B.: Bioorg. Med. Chem. Lett. 12, 1 (2002).
8. Arya D. P., Warner P. M., Jebaratnam D. J.: Tetrahedron Lett. 34, 7823 (1998).
9. Bartulewicz D., Bielawski K., Bielawska A.: Arch. Pharm. Pharm. Med. Chem. 9, 422 (2002).
10. Pućkowska A., Bielawski K., Bielawska A., Midura-Nowaczek K.: Eur. J. Med. Chem. 39, 99 (2004).
11. Forrow M. S., Lee M., Souhami R. L., Hartley J. A.: Chem.-Biol. Interact. 96, 125 (1995).
12. Sidorova N. Y., Gazoni P., Rau D. C.: J. Biomol. Struct. Dyn. 13, 367 (1995).
13. Lee M., Rhodes A. L., Wyatt M. D., D'Incalci M., Forrow S., Hartley J. A.: J. Med. Chem., 36, 863 (1993).
14. Wyatt M. D., Garbiras B. J., Haskell M. K., Lee M., Souhami R. L., Hartley J. A.: Anti-Cancer Drug Des. 9, 511 (1994).
15. Morgan A. R., Lee J. S., Pulleyblank D. F., Murray N. L., Evans D.H.: Nucleic Acids Res. 7, 547 (1997).
16. Bielawski K., Bielawska A., Bartulewicz D., Różański A.: Acta Biochim. Polon. 47, 855 (2000).
17. Khorlin A. A., Krylov A.S., Grokhovsky S.L., Zhuze A. L., Zasadatelev A. S., Gursky G. V., Gottikh B. P.: FEBS Lett. 118, 311 (1980).
18. Beerman T. A., Woynarowski J. M., Sigmund R. D., Gawron L. S., Rao K. E., Lown J. W.: Biochim. Biophys. Acta 1090, 52 (1991).
19. Bartulewicz D., Bielawski K., Bielawska A., Różański A.: Eur. J. Med. Chem. 36, 461 (2001).